Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 10Recruiting 6Withdrawn 4Terminated 3Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Leukemia, Myeloid, Acute 5Prostatic Neoplasms 4Multiple Myeloma 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myelodysplastic Syndromes 1Metastatic HER2-positive Breast Cancer With Brain Metastasis 1Leukemia, Biphenotypic, Acute 1Leukemia 1Insulinoma 1Hyperinsulinism 1Fallopian Tube Neoplasms 1Desmoplastic Small Round Cell Tumor 1Congenital Hyperinsulinism 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma 1Burkitt Lymphoma 1Adenocarcinoma 1

Interventions

Docetaxel 11Prednisone 10Leuprolide 10Magnetic Resonance Spectroscopy 9bicalutamide 8Radiotherapy 7Abiraterone Acetate 7Biopsy 6gallium 68 PSMA-11 5acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5Surveys and Questionnaires 5Metformin 5Goserelin 5radium Ra 223 dichloride 4enzalutamide 4apalutamide 4Specimen Handling 4Injections 4Androgen Antagonists 4pembrolizumab 3orteronel 3cabazitaxel 3abiraterone 3Radiotherapy, Intensity-Modulated 3Radiosurgery 3Pioglitazone 3Paclitaxel 3Exercise 3Brachytherapy 3Blood Specimen Collection 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Prostatic Neoplasms × Injections × Clear all
NCT05333432 2025-06-25

HRPCa-II

Assistance Publique - Hôpitaux de Paris

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

NCT03709550 2022-10-05

Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Roswell Park Cancer Institute

Phase 1/2 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT04272645 2020-07-15

Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer

University of Michigan Rogel Cancer Center

Phase 2 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT02647983 2020-01-22

Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) Injection

Sunnybrook Health Sciences Centre

Phase 1 Withdrawn
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡